Task order 20: 4-thio-2-deoxycytidine capsules
Ended Awarded Last action
- Contract number
- HHSN26100020
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $77,283
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $77,283.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Original award | $77,283 |
About this award
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $77,283 task order is for the manufacture of 4-thio-2-deoxycytidine capsules, which are likely being developed for use in the NCI's cancer research and clinical trials programs. Societal CDMO San Diego holds multiple federal contract Indefinite Delivery Vehicles (IDVs) with various NIH components, including the $45 million Drug Formulation and Manufacturing Contracts 2019 IDV, through which this task order was awarded. The company also has IDVs with the Department of Veterans Affairs (VA) to produce imiquimod cream formulations for the VA's cancer prevention research initiatives. This contract award does not utilize any set-aside designation.
Quick answers
Who was awarded contract HHSN26100020?
HHSN26100020 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on March 10, 2017.
How much is contract HHSN26100020 worth?
The government has obligated $77,283 on HHSN26100020.
Is contract HHSN26100020 an order under another contract?
Yes. HHSN26100020 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract HHSN26100020 competed?
The extent of competition for HHSN26100020 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award